An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation

Shengze Yu, Amira Alkharusi, Gunnar Norstedt, Torbjörn Gräslund*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds